-+ 0.00%
-+ 0.00%
-+ 0.00%

Context Therapeutics Q2 EPS $(0.15) Misses $(0.09) Estimate

Benzinga·08/05/2026 22:04:26
Listen to the news
Context Therapeutics (NASDAQ:CNTX) reported quarterly losses of $(0.15) per share which missed the analyst consensus estimate of $(0.09) by 66.67 percent. This is a 66.67 percent decrease over losses of $(0.09) per share from the same period last year.